-
961
AVAILABILITY AND ACCEPTABILITY OF COVID-19 VACCINE AMONG NON-TEACHING STAFF OF LAGOS STATE UNIVERSITY, OJO, LAGOS
Published 2024-07-01Subjects: Get full text
Article -
962
N-Terminal Plasmodium vivax Merozoite Surface Protein-1, a Potential Subunit for Malaria Vivax Vaccine
Published 2013-01-01“…The lack of in vitro cultures for P. vivax represents a major delay in developing a functional malaria vaccine. One of the major candidates to antimalarial vaccine is the merozoite surface protein-1 (MSP1), which is expressed abundantly on the merozoite surface and capable of activating the host protective immunity. …”
Get full text
Article -
963
The Adoption Process to Technology Biosecurity and Vaccination in the Dispersal of Foot and Mouth Disease Bone Regency, South Sulawesi Province
Published 2025-01-01“… Adopting biosecurity and vaccination technology is one of the steps that can be taken to overcome and minimize FMD disease in beef cattle farming. …”
Get full text
Article -
964
Ecological study of the association between the English national vaccination programme and area deprivation inequalities in COVID-19 mortality
Published 2025-01-01“…However, more could be achieved if barriers to vaccination uptake in the most deprived areas are overcome.…”
Get full text
Article -
965
The immunogenicity of PRV ΔgE/TK/UL49.5 three-gene-deleted vaccine in mice
Published 2025-02-01“…Abstract Background Pseudorabies (PR) caused by the re-emerging of pseudorabies virus (PRV) variant has outbroken among PRV vaccine immunized swine in many pig farms, which has caused serious social and economic consequences since the end of 2011. …”
Get full text
Article -
966
Corrigendum: A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection
Published 2025-02-01Subjects: Get full text
Article -
967
A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2
Published 2022-01-01“…In this case report, we present a female who developed a DVT four days after receiving the J&J vaccine. We propose that the administration of this vaccine may further increase the risk of developing DVTs in patients with previous risk factors, and we hope to use this case to support screening all patients for previous risk factors for thrombosis before administration of the J&J vaccine.…”
Get full text
Article -
968
Vaccination ARN messager (ARNm), modèle de transition de la biologie fondamentale à la médecine
Published 2024-01-01Subjects: Get full text
Article -
969
Prevalence of COVID-19 Vaccine Hesitancy Among Healthcare Workers in Nigeria: A Systematic Review and Meta-Analysis
Published 2025-02-01Subjects: Get full text
Article -
970
Association between leukocyte telomere length and specific antibody levels after vaccination against tick-borne encephalitis
Published 2020-01-01Subjects: Get full text
Article -
971
Regional disparities of full pentavalent vaccine uptake and the determinants in Ethiopia: Mapping and spatial analysis using the EDHS data.
Published 2025-01-01“…<h4>Result</h4>The national full pentavalent vaccine uptake was 59.2%. The spatial distribution of full pentavalent vaccine uptake was not uniform in Ethiopia. …”
Get full text
Article -
972
In silico development of a multi-epitope-based vaccine against Burkholderia cepacia complex using reverse vaccinology
Published 2025-01-01Subjects: Get full text
Article -
973
Acute Myopericarditis after the Second Dose of mRNA COVID-19 Vaccine Mimicking Acute Coronary Syndrome
Published 2022-01-01“…Myocarditis is a rare adverse event of vaccination. Recently, mRNA vaccines for COVID-19 have been reported to correlate with myocarditis, specifically in adolescents and young men. …”
Get full text
Article -
974
Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial.
Published 2011-10-01“…<h4>Background</h4>Introduction of pneumococcal conjugate vaccines (PCVs) of limited valency is justified in Africa by the high burden of pneumococcal disease. …”
Get full text
Article -
975
A Fractional-Order Investigation of Vaccinated SARS-CoV-2 Epidemic Model with Caputo Fractional Derivative
Published 2022-01-01Get full text
Article -
976
Vaccination with Enzymatically Cleaved GPI-Anchored Proteins from Schistosoma mansoni Induces Protection against Challenge Infection
Published 2012-01-01“…Current schistosomiasis control strategies are mainly based on chemotherapy, but many researchers believe that the best long-term strategy to control schistosomiasis is through immunization with an antischistosomiasis vaccine combined with drug treatment. In the search for potential vaccine candidates, numerous tegument antigens have been assessed. …”
Get full text
Article -
977
Long-term effects of SARS-CoV-2 infection and vaccination in a population-based pediatric cohort
Published 2025-01-01Subjects: Get full text
Article -
978
Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies
Published 2025-12-01Subjects: “…9-valent HPV vaccine…”
Get full text
Article -
979
Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated COVID-19 vaccine
Published 2025-01-01Subjects: Get full text
Article -
980
The influence of HARP (The Health Access for Refugees’ Project) on vaccine hesitancy in people seeking asylum and refugees in Northern England
Published 2025-12-01Subjects: Get full text
Article